Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Burundi has experienced significant growth in recent years. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Burundi have shifted towards natural and herbal remedies. Consumers are becoming more conscious of their health and are opting for products that are perceived to be safer and more natural. This preference for natural remedies is in line with global trends, where consumers are increasingly seeking out alternative and holistic approaches to healthcare. Trends in the Digestive & Intestinal Remedies (Pharmacies) market in Burundi include the growing demand for probiotics and digestive enzymes. Probiotics are beneficial bacteria that help maintain a healthy balance of gut flora, while digestive enzymes aid in the breakdown of food and improve digestion. These products are becoming increasingly popular as consumers become more aware of the importance of gut health and its impact on overall well-being. Another trend in the market is the increasing availability of over-the-counter (OTC) digestive and intestinal remedies. Previously, these products were only available through prescription, but now consumers can easily purchase them from pharmacies without the need for a doctor's recommendation. This has made these remedies more accessible to a wider range of consumers, leading to increased sales and market growth. Local special circumstances in Burundi, such as a growing middle class and increasing healthcare expenditure, have contributed to the development of the Digestive & Intestinal Remedies (Pharmacies) market. As the economy improves and disposable incomes rise, consumers are able to afford healthcare products and are willing to spend more on their health and well-being. This has created a favorable environment for the growth of the market. Underlying macroeconomic factors, such as population growth and urbanization, have also played a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Burundi. As the population increases and more people move to urban areas, the demand for healthcare products and services, including digestive and intestinal remedies, is expected to rise. This presents opportunities for market expansion and growth in the coming years. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in Burundi is developing due to changing customer preferences towards natural remedies, the growing demand for probiotics and digestive enzymes, the increasing availability of OTC remedies, local special circumstances such as a growing middle class and increasing healthcare expenditure, and underlying macroeconomic factors such as population growth and urbanization. These factors are driving market growth and creating opportunities for both local and international players in the market.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
